Skip to Main Content

BC200-Driven Translational Regulation as a Therapeutic Target and Biomarker in Tubo-Ovarian High-Grade Serous Carcinoma

Electrochemical Quantification of Chemotherapy Resistance

Delving deeper into chaos of ovarian cancer genomes—from telomere-to-telomere

In vivo modelling of chromosome instability in tubo-ovarian high grade serous carcinoma

The Manitoba Ovarian Cancer Biobank Program (MOBP)

Testing the in vitro mechanism and in vivo efficacy of an experimental drug to kill epithelial ovarian cancer

Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer

Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells

Exploring and exploiting aberrant RBX1 expression in high-grade serous ovarian cancer